Up-regulation of lysozyme production in colonic adenomas and adenocarcinomas

Histopathology

Volumn 32, Issue 2, 1998, Pages 126-132

  Yuen, S T ^a   Wong, M P ^a   Chung, L P ^a   Chan, S Y ^a   Cheung, N ^a   Ho, J ^a   Leung, S Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adenocarcinoma; Adenoma; Large intestine; Lysozyme

Indexed keywords

LYSOZYME;

ARTICLE; CANCER INVASION; COLON ADENOCARCINOMA; COLON ADENOMA; COLON MUCOSA; DYSPLASIA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADENOMA; COLONIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINAL MUCOSA; MURAMIDASE; RANDOM ALLOCATION; RNA, MESSENGER; UP-REGULATION;

EID: 0031906774     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1998.00339.x     Document Type: Article

References (32)

1. Sarker SA, Gyr K. Non-immunological defence mechanisms of the gut. Gut 1992: 33; 987-993.
2. Montero C, Erlandsen SL. Immunocytochemical and histochemical studies on intestinal epithelial cells producing both lysozyme and mucosubstance. Anat. Ret. 1978: 190; 127-141.
3. Isaacson P. Crypt cell carcinoma of the appendix (so-called adenocarcinoid tumour). Am. J. Surg. Pathol. 1981: 5; 213-224.
4. Klockars M, Reitamo S. Tissue distribution of lysozyme in man. J. Histochem. Cytochem. 1975: 23; 932-940.
5. Isaacson P. Immunoperoxidase study of the secretory immunoglobulin system and lysozyme in normal and diseased gastric mucosa. Gut 1982: 23; 578-588.
6. Saito H, Kasajima T, Masuda A, Imai Y, Ishikawa M. Lysozyme localization in human gastric and duodenal epithelium. An immunocytochemical study. Cell Tissue Res. 1988: 251; 307-313.
7. Mason DY, Taylor CR. The distribution of muramidase (lysozyme) in human tissues. J. Clin. Pathol. 1975: 28; 124-132.
8. Reitamo S, Klockars M, Adinolfi M, Osserman EF. Human lysozyme (origin and distribution in health and disease). Ric. Clin. Lab 1978: 8; 211-231.
9. Ho SB, Itzkowitz SH, Friera AM, Jiang SH, Kim YS. Cell lineage markers in premalignant and malignant colonic mucosa. Gastroenterology 1989: 97; 392-404.
10. Santini D, Pasquinelli G, Mazzoleni G, et al. Lysozyme localization in normal and diseased human gastric and colonic mucosa. A correlative histochemical, immunohistochemical and immunoelectron microscopic investigation. APMIS 1992: 100; 575-585.
11. Kittas C, Aroni K, Kotsis L, Papadimitriou CS. Distribution of lysozyme, alpha 1-antichymotrypsin and alpha 1-antitrypsin in adenocarcinomas of the stomach and large intestine. An immunohistochemical study. Virchows Arch. A Pathol. Anat. Histopathol. 1982: 398; 139-147.
12. Tahara E, Ito H, Shimamoto F, Iwamoto T, Nakagami K, Niimoto H. Lysozyme in human gastric carcinoma: a retrospective immunohistochemical study. Histopathology 1982: 6; 409-421.
13. Ito H, Yokozaki H, Ito M, Tahara E. Papillary adenoma of the stomach. Pathologic and immunohistochemical study. Arch. Pathol. Lab. Med. 1989: 113: 1030-1034.
14. Ito H, Yasui W, Yoshida K, Nakayama H, Tahara E. Depressed tubular adenoma of the stomach: pathological and immunohistochemical features. Histopathology 1990: 17; 419-426.
15. Heitz PU, Wegmann W. Identification of neoplastic Paneth cells in an adenocarcinoma of the stomach using lysozyme as a marker, and electron microscopy. Virchows Arch. Pathol. Anat. 1980: 386; 107-116.
16. Capella C, Cornaggia M, Usellini L et al. Neoplastic cells containing lysozyme in gastric carcinomas. Pathology 1984: 16; 87-92.
17. Balazs T, Roepke RR. Lysozymuria induced in rats hy nephrotoxic agents. Proc. Soc. Exp. Biol. Med. 1966: 123; 380-385.
18. Fett JW, Strydom DJ, Lobb RR et al. Lysozyme: a major secretory product of a human colon carcinoma cell line. Biochemistry 1985: 24; 965-975.
19. Fett JW, Lobb RR, Alderman EM, Key ME. Immunocytochemical and enzymatic detection of lysozyme in human colon carcinoma cell lines. Experientia 1986: 42; 1159-1162.
20. Cappello M, Keshav S, Prince C, Jewell DP, Gordon S. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 1992: 33; 1214-1219.
21. Currie G. Prognostic significance of serum lysozyme in adult acute myelogenous leukaemia. Br. J. Haematol. 1976: 1; 835-837.
22. Scott CS, Stark AN, Limbert HJ, Master PS, Head C, Roberts BE. Diagnostic and prognostic factors in acute monocytic leukaemia: an analysis of 51 cases. Br. J. Haematol. 1988: 69; 247-252.
23. Stark AN, Thorogood J, Head C, Roberts BE, Scott CS. Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML). Br. J. Cancer 1987: 56; 59-63.
24. Costongs GM, Hemrika MH, Engels LG, et al. Faecal lysozyme: determination, reference intervals and some data in gastrointestinal disease. Clin. Chim. Acta 1987: 167; 125-134.
25. Tichy M, Bures J, Jandik P. Importance of determining lysozyme in colorectal cancer. Sb. Ved. Pr. Lek. Fak. Karlovy Univerzity Hradci Kralove 1990: 33; 345-349.
26. Yuen ST, Chung LP, Leung SY, Luk IS, Chan SY, Ho J. In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am. J. Surg. Pathol. 1994: 18; 1158-1163.
27. Pittaluga S, Wong MP, Chung LP, Loke SL. Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the lung. Am. J. Surg. Pathol. 1993: 17; 678-682.
28. Brandtzaeg P. Transport models for secretory IgA and secretory IgM. Clin. Exp. Immunol. 1981: 44; 221-232.
29. Dubrow R, Kim CS, Eldred AK. Fecal lysozyme: an unreliable marker for colorectal cancer. Am. J. Gastroenterol. 1992: 87; 617-621.
30. Dobbins JW, Binder HJ, Spiro HM, Finch SC. Serum lysozyme in inflammatory bowel disease. Gastroenterology 1976: 70; 469-471.
31. Falchuk KR, Perrotto JL, Isselbacher KJ. Serum lysozyme in Crohn's disease and ulcerative colitis. N. Engl. J. Med. 1975: 292; 395-397.
32. Stamp GW, Poulsom R, Chung LP, et al. Lysozyme gene expression in inflammatory bowel disease. Gastroenterology 1992: 103; 532-538.